SavedAdd your journal

Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 5

Nonmalignant Lung Pathologies Showing18F-Fluorodeoxyglucose Positron EmissionTomography/Computed Tomography Positivity

Fatma Sema OYMAK
Sevim YENİGÜN
İnci GÜLMEZ
Nuri TUTAR
Burcu Baran KETENCİOĞLU
Pages
452–457
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The median SUVmax value of anthracotic lesions was significantly lower than the median SUVmax value of granulomatous and OP lesions (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) not only givesinformation about anatomical features of lung lesions but also about their metabolic activity.
📊
Key Findings & Data:Materials and Methods: This study retrospectively analyzed 1,924 subjects that underwent 18F-FDG PET/CT from Decem ber 2010 to January 2015.
💡
Conclusion & Impact:The median SUVmax value of anthracotic lesions was significantly lower than the median SUVmax value of granulomatous and OP lesions (p
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) not only givesinformation about anatomical features of lung lesions but also about their metabolic activity. This study aimed to determinethe mediastinal and parenchymal pathologies of the lung with false-positive FDG involvement and characteristics that couldbenefit differential diagnosis. Materials and Methods: This study retrospectively analyzed 1,924 subjects that underwent 18F-FDG PET/CT from Decem ber 2010 to January 2015. Subjects with a maximum standardized uptake value (SUVmax) value of ≥2.5 in the lung tissue,mediastinal lymph nodes with no primary lung malignancy, and a benign pathology result were included. Results: The mean age of the 143 subjects was 61.7±11.0 years. The pathologies anthracosis, granulomatous inflam matory events, and organized pneumonia (OP) were 64 (45%), 36 (25%), and 18 (13%) cases, respectively, in order offrequency. The median SUVmax value of all lesions was 5.2 (min–max, 2.5–37.6). Moreover, mediastinal lymph node involve ment was frequent (59%). The median SUVmax value of anthracotic lesions was significantly lower than the median SUVmax value of granulomatous and OP lesions (p

🔖

Cite This Article

OYMAK, F. S., YENİGÜN, S., GÜLMEZ, İ., TUTAR, N., KETENCİOĞLU, B. B. (2022). Nonmalignant Lung Pathologies Showing18F-Fluorodeoxyglucose Positron EmissionTomography/Computed Tomography Positivity. Erciyes Medical Journal, Cilt: 43 - Sayı: 5, 452–457. https://ajindex.com/articles/502215

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394–424
  2. Jia Y, Gong W, Zhang Z, Tu G, Li J, Xiong F, et al. Comparing the diagnostic value of 18F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis. J Thorac Dis 2019; 11(5): 2082–98
  3. Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, et al. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med 2006; 47(3): 426–31
  4. Shroff GS, Sabloff BS, Truong MT, Carter BW, Viswanathan C. PET/CT Interpretative Pitfalls in Thoracic Malignancies. Semin Ultrasound CT MR 2018; 39(3): 282–8
  5. Niyonkuru A, Chen X, Bakari KH, Wimalarathne DN, Bouhari A, Arnous MMR, et al. Evaluation of the diagnostic efficacy of 18 F-Fluorine-2-Deoxy-D-Glucose PET/CT for lung cancer and pulmonary tuberculosis in a Tuberculosis-endemic Country. Cancer Med 2020; 9(3): 931–42
  6. Capitanio S, Nordin AJ, Noraini AR, Rossetti C. PET/CT in nononcological lung diseases: current applications and future perspectives. Eur Respir Rev 2016; 25(141): 247–58
  7. Zhao M, Xin XF, Hu H, Pan XH, Lv TF, Liu HB, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of benign pulmonary lesions in sarcoidosis. Transl Lung Cancer Res 2019; 8(3): 208–13
  8. Yu C, Xia X, Qin C, Sun X, Zhang Y, Lan X. Is SUVmax helpful in the differential diagnosis of enlarged mediastinal lymph nodes? A Pilot study. Contrast Media Mol Imaging 2018; 2018: 3417190
  9. Lee J, Kim YK, Seo YY, Choi EK, Lee DS, Kim YS, et al. Clinical characteristics of false-positive lymph node on Chest CT or PET-CT confirmed by endobronchial ultrasound-guided transbronchial needle aspiration in lung cancer. Tuberc Respir Dis (Seoul) 2018; 81(4): 339–46
  10. Hewitt RJ, Wright C, Adeboyeku D, Ornadel D, Berry M, Wickremasinghe M, et al. Primary nodal anthracosis identified by EBUS-TBNA as a cause of FDG PET/CT positive mediastinal lymphadenopathy. Respir Med Case Rep 2013; 10: 48–52
  11. Lin WY, Hsu WH, Lin KH, Wang SJ. Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer. J Chin Med Assoc 2012; 75(5): 203–8
  12. Gupta A, Shah A. Bronchial anthracofibrosis: an emerging pulmonary disease due